The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Purpura Therapy Drugs Market Research Report 2025
Synopsis
Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis
The global Purpura Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Purpura Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Purpura Therapy Drugs.
Report Scope
The Purpura Therapy Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Purpura Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Purpura Therapy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee's Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
Roch
Segment by Type
Allergic Purpura
Thrombocytopenic Purpura
Segment by Application
Hospital Use
Clinic Use
Household
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Purpura Therapy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Purpura Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Purpura is one of the common hemorrhagic diseases in children, which is characterized by blood spillage under skin and mucous membrane, petechiae and pressure stasis
The global Purpura Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Purpura Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Purpura Therapy Drugs.
Report Scope
The Purpura Therapy Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Purpura Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Purpura Therapy Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb Company
Pfizer Inc
GlaxoSmithKline Plc
Novartis AG
Hovione
Sanofi Winthrop Industrie S.A.
Hoffman-L Roche
Amgen Inc
Grifols Biologicals Inc
Ablynx NV
Biogen Inc
KM Biologics
Lee's Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
Roch
Segment by Type
Allergic Purpura
Thrombocytopenic Purpura
Segment by Application
Hospital Use
Clinic Use
Household
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Purpura Therapy Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Purpura Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Purpura Therapy Drugs Market Overview
1.1 Product Overview and Scope of Purpura Therapy Drugs
1.2 Purpura Therapy Drugs Segment by Type
1.2.1 Global Purpura Therapy Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Allergic Purpura
1.2.3 Thrombocytopenic Purpura
1.3 Purpura Therapy Drugs Segment by Application
1.3.1 Global Purpura Therapy Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Others
1.4 Global Purpura Therapy Drugs Market Size Estimates and Forecasts
1.4.1 Global Purpura Therapy Drugs Revenue 2019-2030
1.4.2 Global Purpura Therapy Drugs Sales 2019-2030
1.4.3 Global Purpura Therapy Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Purpura Therapy Drugs Market Competition by Manufacturers
2.1 Global Purpura Therapy Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Purpura Therapy Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Purpura Therapy Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Purpura Therapy Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Purpura Therapy Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Purpura Therapy Drugs, Product Type & Application
2.7 Purpura Therapy Drugs Market Competitive Situation and Trends
2.7.1 Purpura Therapy Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Purpura Therapy Drugs Players Market Share by Revenue
2.7.3 Global Purpura Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Purpura Therapy Drugs Retrospective Market Scenario by Region
3.1 Global Purpura Therapy Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Purpura Therapy Drugs Global Purpura Therapy Drugs Sales by Region: 2019-2030
3.2.1 Global Purpura Therapy Drugs Sales by Region: 2019-2024
3.2.2 Global Purpura Therapy Drugs Sales by Region: 2025-2030
3.3 Global Purpura Therapy Drugs Global Purpura Therapy Drugs Revenue by Region: 2019-2030
3.3.1 Global Purpura Therapy Drugs Revenue by Region: 2019-2024
3.3.2 Global Purpura Therapy Drugs Revenue by Region: 2025-2030
3.4 North America Purpura Therapy Drugs Market Facts & Figures by Country
3.4.1 North America Purpura Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Purpura Therapy Drugs Sales by Country (2019-2030)
3.4.3 North America Purpura Therapy Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Purpura Therapy Drugs Market Facts & Figures by Country
3.5.1 Europe Purpura Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Purpura Therapy Drugs Sales by Country (2019-2030)
3.5.3 Europe Purpura Therapy Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Purpura Therapy Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Purpura Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Purpura Therapy Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Purpura Therapy Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Purpura Therapy Drugs Market Facts & Figures by Country
3.7.1 Latin America Purpura Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Purpura Therapy Drugs Sales by Country (2019-2030)
3.7.3 Latin America Purpura Therapy Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Purpura Therapy Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Purpura Therapy Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Purpura Therapy Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Purpura Therapy Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Purpura Therapy Drugs Sales by Type (2019-2030)
4.1.1 Global Purpura Therapy Drugs Sales by Type (2019-2024)
4.1.2 Global Purpura Therapy Drugs Sales by Type (2025-2030)
4.1.3 Global Purpura Therapy Drugs Sales Market Share by Type (2019-2030)
4.2 Global Purpura Therapy Drugs Revenue by Type (2019-2030)
4.2.1 Global Purpura Therapy Drugs Revenue by Type (2019-2024)
4.2.2 Global Purpura Therapy Drugs Revenue by Type (2025-2030)
4.2.3 Global Purpura Therapy Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Purpura Therapy Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Purpura Therapy Drugs Sales by Application (2019-2030)
5.1.1 Global Purpura Therapy Drugs Sales by Application (2019-2024)
5.1.2 Global Purpura Therapy Drugs Sales by Application (2025-2030)
5.1.3 Global Purpura Therapy Drugs Sales Market Share by Application (2019-2030)
5.2 Global Purpura Therapy Drugs Revenue by Application (2019-2030)
5.2.1 Global Purpura Therapy Drugs Revenue by Application (2019-2024)
5.2.2 Global Purpura Therapy Drugs Revenue by Application (2025-2030)
5.2.3 Global Purpura Therapy Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Purpura Therapy Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb Company
6.1.1 Bristol-Myers Squibb Company Corporation Information
6.1.2 Bristol-Myers Squibb Company Description and Business Overview
6.1.3 Bristol-Myers Squibb Company Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bristol-Myers Squibb Company Purpura Therapy Drugs Product Portfolio
6.1.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.2 Pfizer Inc
6.2.1 Pfizer Inc Corporation Information
6.2.2 Pfizer Inc Description and Business Overview
6.2.3 Pfizer Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc Purpura Therapy Drugs Product Portfolio
6.2.5 Pfizer Inc Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Corporation Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GlaxoSmithKline Plc Purpura Therapy Drugs Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Purpura Therapy Drugs Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Hovione
6.5.1 Hovione Corporation Information
6.5.2 Hovione Description and Business Overview
6.5.3 Hovione Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hovione Purpura Therapy Drugs Product Portfolio
6.5.5 Hovione Recent Developments/Updates
6.6 Sanofi Winthrop Industrie S.A.
6.6.1 Sanofi Winthrop Industrie S.A. Corporation Information
6.6.2 Sanofi Winthrop Industrie S.A. Description and Business Overview
6.6.3 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product Portfolio
6.6.5 Sanofi Winthrop Industrie S.A. Recent Developments/Updates
6.7 Hoffman-L Roche
6.6.1 Hoffman-L Roche Corporation Information
6.6.2 Hoffman-L Roche Description and Business Overview
6.6.3 Hoffman-L Roche Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hoffman-L Roche Purpura Therapy Drugs Product Portfolio
6.7.5 Hoffman-L Roche Recent Developments/Updates
6.8 Amgen Inc
6.8.1 Amgen Inc Corporation Information
6.8.2 Amgen Inc Description and Business Overview
6.8.3 Amgen Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amgen Inc Purpura Therapy Drugs Product Portfolio
6.8.5 Amgen Inc Recent Developments/Updates
6.9 Grifols Biologicals Inc
6.9.1 Grifols Biologicals Inc Corporation Information
6.9.2 Grifols Biologicals Inc Description and Business Overview
6.9.3 Grifols Biologicals Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Grifols Biologicals Inc Purpura Therapy Drugs Product Portfolio
6.9.5 Grifols Biologicals Inc Recent Developments/Updates
6.10 Ablynx NV
6.10.1 Ablynx NV Corporation Information
6.10.2 Ablynx NV Description and Business Overview
6.10.3 Ablynx NV Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ablynx NV Purpura Therapy Drugs Product Portfolio
6.10.5 Ablynx NV Recent Developments/Updates
6.11 Biogen Inc
6.11.1 Biogen Inc Corporation Information
6.11.2 Biogen Inc Purpura Therapy Drugs Description and Business Overview
6.11.3 Biogen Inc Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biogen Inc Purpura Therapy Drugs Product Portfolio
6.11.5 Biogen Inc Recent Developments/Updates
6.12 KM Biologics
6.12.1 KM Biologics Corporation Information
6.12.2 KM Biologics Purpura Therapy Drugs Description and Business Overview
6.12.3 KM Biologics Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 KM Biologics Purpura Therapy Drugs Product Portfolio
6.12.5 KM Biologics Recent Developments/Updates
6.13 Lee's Pharmaceutical Holdings Ltd
6.13.1 Lee's Pharmaceutical Holdings Ltd Corporation Information
6.13.2 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Description and Business Overview
6.13.3 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product Portfolio
6.13.5 Lee's Pharmaceutical Holdings Ltd Recent Developments/Updates
6.14 Omeros Corp
6.14.1 Omeros Corp Corporation Information
6.14.2 Omeros Corp Purpura Therapy Drugs Description and Business Overview
6.14.3 Omeros Corp Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Omeros Corp Purpura Therapy Drugs Product Portfolio
6.14.5 Omeros Corp Recent Developments/Updates
6.15 Takeda
6.15.1 Takeda Corporation Information
6.15.2 Takeda Purpura Therapy Drugs Description and Business Overview
6.15.3 Takeda Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Takeda Purpura Therapy Drugs Product Portfolio
6.15.5 Takeda Recent Developments/Updates
6.16 Roch
6.16.1 Roch Corporation Information
6.16.2 Roch Purpura Therapy Drugs Description and Business Overview
6.16.3 Roch Purpura Therapy Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Roch Purpura Therapy Drugs Product Portfolio
6.16.5 Roch Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Purpura Therapy Drugs Industry Chain Analysis
7.2 Purpura Therapy Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Purpura Therapy Drugs Production Mode & Process
7.4 Purpura Therapy Drugs Sales and Marketing
7.4.1 Purpura Therapy Drugs Sales Channels
7.4.2 Purpura Therapy Drugs Distributors
7.5 Purpura Therapy Drugs Customers
8 Purpura Therapy Drugs Market Dynamics
8.1 Purpura Therapy Drugs Industry Trends
8.2 Purpura Therapy Drugs Market Drivers
8.3 Purpura Therapy Drugs Market Challenges
8.4 Purpura Therapy Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Purpura Therapy Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Purpura Therapy Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Purpura Therapy Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Purpura Therapy Drugs Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Purpura Therapy Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Purpura Therapy Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Purpura Therapy Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Purpura Therapy Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Purpura Therapy Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Purpura Therapy Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Purpura Therapy Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Purpura Therapy Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Purpura Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Purpura Therapy Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Purpura Therapy Drugs Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Purpura Therapy Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Purpura Therapy Drugs Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Purpura Therapy Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Purpura Therapy Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Purpura Therapy Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Purpura Therapy Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Purpura Therapy Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Purpura Therapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Purpura Therapy Drugs Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Purpura Therapy Drugs Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Purpura Therapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Purpura Therapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Purpura Therapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Purpura Therapy Drugs Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Purpura Therapy Drugs Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Purpura Therapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Purpura Therapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Purpura Therapy Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Purpura Therapy Drugs Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Purpura Therapy Drugs Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Purpura Therapy Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Purpura Therapy Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Purpura Therapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Purpura Therapy Drugs Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Purpura Therapy Drugs Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Purpura Therapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Purpura Therapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Purpura Therapy Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Purpura Therapy Drugs Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Purpura Therapy Drugs Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Purpura Therapy Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Purpura Therapy Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Purpura Therapy Drugs Sales (K Pcs) by Type (2019-2024)
Table 51. Global Purpura Therapy Drugs Sales (K Pcs) by Type (2025-2030)
Table 52. Global Purpura Therapy Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Purpura Therapy Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Purpura Therapy Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Purpura Therapy Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Purpura Therapy Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Purpura Therapy Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Purpura Therapy Drugs Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Purpura Therapy Drugs Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Purpura Therapy Drugs Sales (K Pcs) by Application (2019-2024)
Table 61. Global Purpura Therapy Drugs Sales (K Pcs) by Application (2025-2030)
Table 62. Global Purpura Therapy Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Purpura Therapy Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Purpura Therapy Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Purpura Therapy Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Purpura Therapy Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Purpura Therapy Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Purpura Therapy Drugs Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Purpura Therapy Drugs Price (USD/Pcs) by Application (2025-2030)
Table 70. Bristol-Myers Squibb Company Corporation Information
Table 71. Bristol-Myers Squibb Company Description and Business Overview
Table 72. Bristol-Myers Squibb Company Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Bristol-Myers Squibb Company Purpura Therapy Drugs Product
Table 74. Bristol-Myers Squibb Company Recent Developments/Updates
Table 75. Pfizer Inc Corporation Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Pfizer Inc Purpura Therapy Drugs Product
Table 79. Pfizer Inc Recent Developments/Updates
Table 80. GlaxoSmithKline Plc Corporation Information
Table 81. GlaxoSmithKline Plc Description and Business Overview
Table 82. GlaxoSmithKline Plc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. GlaxoSmithKline Plc Purpura Therapy Drugs Product
Table 84. GlaxoSmithKline Plc Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Novartis AG Purpura Therapy Drugs Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Hovione Corporation Information
Table 91. Hovione Description and Business Overview
Table 92. Hovione Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Hovione Purpura Therapy Drugs Product
Table 94. Hovione Recent Developments/Updates
Table 95. Sanofi Winthrop Industrie S.A. Corporation Information
Table 96. Sanofi Winthrop Industrie S.A. Description and Business Overview
Table 97. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Sanofi Winthrop Industrie S.A. Purpura Therapy Drugs Product
Table 99. Sanofi Winthrop Industrie S.A. Recent Developments/Updates
Table 100. Hoffman-L Roche Corporation Information
Table 101. Hoffman-L Roche Description and Business Overview
Table 102. Hoffman-L Roche Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Hoffman-L Roche Purpura Therapy Drugs Product
Table 104. Hoffman-L Roche Recent Developments/Updates
Table 105. Amgen Inc Corporation Information
Table 106. Amgen Inc Description and Business Overview
Table 107. Amgen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Amgen Inc Purpura Therapy Drugs Product
Table 109. Amgen Inc Recent Developments/Updates
Table 110. Grifols Biologicals Inc Corporation Information
Table 111. Grifols Biologicals Inc Description and Business Overview
Table 112. Grifols Biologicals Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Grifols Biologicals Inc Purpura Therapy Drugs Product
Table 114. Grifols Biologicals Inc Recent Developments/Updates
Table 115. Ablynx NV Corporation Information
Table 116. Ablynx NV Description and Business Overview
Table 117. Ablynx NV Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. Ablynx NV Purpura Therapy Drugs Product
Table 119. Ablynx NV Recent Developments/Updates
Table 120. Biogen Inc Corporation Information
Table 121. Biogen Inc Description and Business Overview
Table 122. Biogen Inc Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Biogen Inc Purpura Therapy Drugs Product
Table 124. Biogen Inc Recent Developments/Updates
Table 125. KM Biologics Corporation Information
Table 126. KM Biologics Description and Business Overview
Table 127. KM Biologics Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. KM Biologics Purpura Therapy Drugs Product
Table 129. KM Biologics Recent Developments/Updates
Table 130. Lee's Pharmaceutical Holdings Ltd Corporation Information
Table 131. Lee's Pharmaceutical Holdings Ltd Description and Business Overview
Table 132. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. Lee's Pharmaceutical Holdings Ltd Purpura Therapy Drugs Product
Table 134. Lee's Pharmaceutical Holdings Ltd Recent Developments/Updates
Table 135. Omeros Corp Corporation Information
Table 136. Omeros Corp Description and Business Overview
Table 137. Omeros Corp Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 138. Omeros Corp Purpura Therapy Drugs Product
Table 139. Omeros Corp Recent Developments/Updates
Table 140. Takeda Corporation Information
Table 141. Takeda Description and Business Overview
Table 142. Takeda Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 143. Takeda Purpura Therapy Drugs Product
Table 144. Takeda Recent Developments/Updates
Table 145. Roch Corporation Information
Table 146. Roch Description and Business Overview
Table 147. Roch Purpura Therapy Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 148. Roch Purpura Therapy Drugs Product
Table 149. Roch Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Purpura Therapy Drugs Distributors List
Table 153. Purpura Therapy Drugs Customers List
Table 154. Purpura Therapy Drugs Market Trends
Table 155. Purpura Therapy Drugs Market Drivers
Table 156. Purpura Therapy Drugs Market Challenges
Table 157. Purpura Therapy Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Purpura Therapy Drugs
Figure 2. Global Purpura Therapy Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Purpura Therapy Drugs Market Share by Type in 2023 & 2030
Figure 4. Allergic Purpura Product Picture
Figure 5. Thrombocytopenic Purpura Product Picture
Figure 6. Global Purpura Therapy Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Purpura Therapy Drugs Market Share by Application in 2023 & 2030
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Household
Figure 11. Others
Figure 12. Global Purpura Therapy Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Purpura Therapy Drugs Market Size (2019-2030) & (US$ Million)
Figure 14. Global Purpura Therapy Drugs Sales (2019-2030) & (K Pcs)
Figure 15. Global Purpura Therapy Drugs Average Price (USD/Pcs) & (2019-2030)
Figure 16. Purpura Therapy Drugs Report Years Considered
Figure 17. Purpura Therapy Drugs Sales Share by Manufacturers in 2023
Figure 18. Global Purpura Therapy Drugs Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Purpura Therapy Drugs Players: Market Share by Revenue in 2023
Figure 20. Purpura Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Purpura Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Purpura Therapy Drugs Sales Market Share by Country (2019-2030)
Figure 23. North America Purpura Therapy Drugs Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Purpura Therapy Drugs Sales Market Share by Country (2019-2030)
Figure 27. Europe Purpura Therapy Drugs Revenue Market Share by Country (2019-2030)
Figure 28. Germany Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Purpura Therapy Drugs Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Purpura Therapy Drugs Revenue Market Share by Region (2019-2030)
Figure 35. China Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Purpura Therapy Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Purpura Therapy Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Purpura Therapy Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Purpura Therapy Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E Purpura Therapy Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Purpura Therapy Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Purpura Therapy Drugs by Type (2019-2030)
Figure 57. Global Purpura Therapy Drugs Price (USD/Pcs) by Type (2019-2030)
Figure 58. Global Sales Market Share of Purpura Therapy Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Purpura Therapy Drugs by Application (2019-2030)
Figure 60. Global Purpura Therapy Drugs Price (USD/Pcs) by Application (2019-2030)
Figure 61. Purpura Therapy Drugs Value Chain
Figure 62. Purpura Therapy Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
